Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,451,124 papers from all fields of science
Search
Sign In
Create Free Account
DG 5128
Known as:
DG-5128
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
midaglizole
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
V. Doze
,
B. X. Chen
,
Z. Li
,
M. Maze
Acta veterinaria Scandinavica. Supplementum
1989
Corpus ID: 23234927
The anesthetic-reducing property of medetomidine far exceeds that seen with other alpha 2-adrenergic agonists (e.g., clonidine…
Expand
1988
1988
Inhibitory Effect of DG-5128 on
Y. Yoshie
,
K. Iizuka
,
Tsugio Nakazawat
1988
Corpus ID: 74656857
To study the possible role of alpha-2 receptors in in- tractable asthmatics, we investigated the ameliorative ef- fects of 2-(2…
Expand
1987
1987
[Inhibitory effect of alpha-2 adrenoceptor antagonist (DG-5128) on intractable asthma].
Y. Yoshie
,
K. Iizuka
,
Y. Umegae
,
S. Kobayashi
,
T. Nakazawa
Arerugi = [Allergy]
1987
Corpus ID: 27610039
1987
1987
Effect of the alpha 2-blocker DG-5128 on insulin and somatostatin release from the isolated perfused rat pancreas.
G. Koh
,
Y. Seino
,
+6 authors
H. Imura
Life Science
1987
Corpus ID: 741784
2[2-(4.5-Dihydro-1H-imidazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquihydrate (DG-5128) is an alpha 2-specific…
Expand
Highly Cited
1986
Highly Cited
1986
New α2-Adrenergic Blocker (DG-5128) Improves Insulin Secretion and In Vivo Glucose Disposal in NIDDM Patients
A. Kashiwagi
,
Y. Harano
,
+4 authors
Y. Shigeta
Diabetes
1986
Corpus ID: 3163776
Effects of oral administration of DG-5128, a new oral hypoglycemic agent, on glycemic control after a mixed meal and an in vivo…
Expand
1985
1985
Selective interaction of DG-5128 with a low agonist affinity state of alpha-2 adrenoceptor.
K. Yamanaka
,
S. Kigoshi
,
I. Muramatsu
Japanese Journal of Pharmacology
1985
Corpus ID: 23856291
Using rat cerebral cortex membranes, the inhibitory effect of DG-5128 against (3H)-clonidine binding was compared between low…
Expand
1985
1985
Contractile action of yohimbine in the dog basilar artery.
M. Oshita
,
S. Kigoshi
,
I. Muramatsu
Blood & Vessel
1985
Corpus ID: 39362479
Yohimbine (10(-8) to 10(-4) M) produced a concentration-dependent contraction of the isolated dog basilar artery. The maximal…
Expand
1984
1984
The selectivity of DG-5128 as an alpha 2-adrenoceptor antagonist.
K. Yamanaka
,
S. Kigoshi
,
I. Muramatsu
European Journal of Pharmacology
1984
Corpus ID: 4550024
DG-5128 (2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate) at concentrations up to 10…
Expand
1982
1982
Insulin releasing action of 2-[2-(4,5-dihydro-1H-imadazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquihydrate (DG-5128), a new, orally effective hypoglycaemic agent.
K. Kameda
,
S. Ono
,
I. Koyama
,
Y. Abiko
Acta Endocrinologica
1982
Corpus ID: 37559593
2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquilhydrate (DG-5128) is a new orally effective…
Expand
1982
1982
Hypoglycemic action of 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate (DG-5128), a new hypoglycemic agent.
K. Kameda
,
S. Ono
,
Y. Abiko
Arzneimittel-Forschung
1982
Corpus ID: 13176949
2-[2-(4,5-Dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate (GD-5128) is a new hypoglycemic agent…
Expand